qol for patients with polycythemia vera or essential thrombocythemia
Published 3 years ago • 533 plays • Length 1:32Download video MP4
Download video MP3
Similar videos
-
3:09
pegylated interferon for the treatment of polycythemia vera and essential thrombocythemia
-
1:26
agents of interest being explored in essential thrombocythemia and polycythemia vera
-
3:21
the current standard of care for patients with essential thrombocythemia
-
10:20
new guidelines for the treatment and management of polycythemia vera
-
3:06
the unmet needs of essential thrombocythemia and polycythemia vera patients
-
0:35
novel therapeutics in essential thrombocythemia
-
1:40
challenges and options for patients with hydroxyurea-resistant pv
-
2:45
safety and efficacy of inotuzumab ozogamicin conditioning for allosct in lymphoid malignancies
-
1:29
karmma-3: qol of patients with tce r/r myeloma treated with ide-cel vs standard regimens
-
1:03
most: an observational study of myelofibrosis and essential thrombocythemia
-
2:12
impact & relationship between symptoms and qol in patients with mpns
-
12:31
myelofibrosis, polycythemia vera, essential thrombocythemia: treatments to watch for | mpn update
-
1:30
the patient perspective of polycythemia vera and second-line treatment options
-
1:57
surpass et: p1101 in essential thrombocythemia
-
1:35
pv-pinpoint: a study investigating the diagnosis and management of polycythemia vera in the uk
-
1:30
the verify trial: rusfertide in patients with polycythemia vera
-
8:07
essential thrombocythemia: outcomes, unmet needs, and therapeutic strategies
-
1:47
bomedemstat normalizes platelet count for essential thrombocythemia
-
1:17
the use of pacritinib in thrombocytopenic patients with myelofibrosis undergoing allosct